Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Unresectable Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01430052
What this trial is testing

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases 110
Early research (Phase 1)UnknownNCT02024633
What this trial is testing

Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Betta Pharmaceuticals Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03910387
What this trial is testing

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

Who this might be right for
Locally Advanced Unresectable Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Pancreatic Adenocarcinoma+2 more
Emory University 23
Testing effectiveness (Phase 2)Ended earlyNCT03736720
What this trial is testing

Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Who this might be right for
Locally Advanced Digestive System Neuroendocrine CarcinomaLocally Advanced Pancreatic Neuroendocrine CarcinomaMetastatic Digestive System Neuroendocrine Carcinoma+5 more
Roswell Park Cancer Institute 11
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT01580397
What this trial is testing

Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
ImmunityBio, Inc. 15
Not applicableStudy completedNCT04727723
What this trial is testing

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Novartis Pharmaceuticals 164
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT03158779
What this trial is testing

Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Istituto Clinico Humanitas 45
Early research (Phase 1)Active Not RecruitingNCT05907304
What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 86
Early research (Phase 1)Study completedNCT01410968
What this trial is testing

A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Cancer
Carolyn Britten 12
Early research (Phase 1)Looking for participantsNCT06454383
What this trial is testing

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

Who this might be right for
Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8+1 more
City of Hope Medical Center 19
Very early researchStudy completedNCT02896907
What this trial is testing

Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 8
Large-scale testing (Phase 3)Looking for participantsNCT07066098
What this trial is testing

Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)

Who this might be right for
Pancreatic Cancer
Innovent Biologics (Suzhou) Co. Ltd. 201
Testing effectiveness (Phase 2)Looking for participantsNCT06885034
What this trial is testing

Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

Who this might be right for
Gastrointestinal Neoplasms
GlaxoSmithKline 451
Early research (Phase 1)Study completedNCT02272738
What this trial is testing

Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases 54
Not applicableLooking for participantsNCT04493632
What this trial is testing

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

Who this might be right for
Pancreatic NeoplasmDigestive System NeoplasmNeoplasms by Site+5 more
OncoSil Medical Limited 500
Testing effectiveness (Phase 2)Ended earlyNCT01688336
What this trial is testing

FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT07600268
What this trial is testing

Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Shandong Cancer Hospital and Institute 24
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Next Page